Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥36.2bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥36.8bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥5.5bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥8.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥5.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥5.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥8.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥6.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥171.7bnat 2023-09-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥167.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥30.9bnat 2023-09-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥140.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥140.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥55.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥70.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.3bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥75.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥245m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥9.3bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥108.182023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.292023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥158.342022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥81.452022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-09-30¥661m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-09-30¥35.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-09-30¥35.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-09-30¥7.6bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-09-30¥616m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥36.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥36.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥8.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember4605000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1215
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember2294000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0606
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1843000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0486
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1474000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0389
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1402000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0370
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1377000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0364
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember852000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0225
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember655000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0173
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember653000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0172
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember642000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0170
Number of shares heldCurrentQuarterInstant15802000
Shareholding ratioCurrentQuarterInstant0.4170
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember8041400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember377880
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember37788000
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember110330
Number of shares issued shares voting rightsCurrentQuarterInstant45939730
Number of voting rights issued shares voting rightsCurrentQuarterInstant377880
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member8041400
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member8041400
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.1750
Number of shares held in own name treasury shares etcCurrentQuarterInstant8041400
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant8041400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1750
Cash and depositsPrior1YearInstant59561000000JPY
Cash and depositsCurrentQuarterInstant55361000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant19268000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant23998000000JPY
Short term investment securitiesPrior1YearInstant14699000000JPY
Short term investment securitiesCurrentQuarterInstant14699000000JPY
Merchandise and finished goodsPrior1YearInstant6734000000JPY
Merchandise and finished goodsCurrentQuarterInstant7719000000JPY
Work in processPrior1YearInstant2481000000JPY
Work in processCurrentQuarterInstant2973000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass